AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Deferred Tax Liabilities · Q3 FY2025 · quarter ended Sep 2025

Deferred tax liabilities of €0 in Q3 FY2025

Q3 FY2025 deferred tax liabilities was €0.

Context

  • Deferred tax liabilities amounted to 0.0% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€0— QoQ
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

Currency unavailable · from the balance sheet

No Deferred Tax Liabilities data reported for this period type.

Deferred Tax Liabilities vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred tax liabilities is compared through growth and share of total assets rather than absolute size.
  • Deferred tax liabilities amounts to 0.0% of total assets for AGMB, versus a peer median of 0.0%.
AGMB Competitors
Deferred Tax Liabilities for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$383K USD-82.1%—0.1%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€0 EUR——0.0%
ANABAnaptysBio, Inc.Mar 2026$0 USD——0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD——0.0%
EQEquillium, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-82.1%—0.0%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.